Search
forResearch 10 of 1000+
- Current and future pharmacotherapy for alopecia areata
- Anticytokine therapy, particularly anti-IFN-γ, in Th1-mediated autoimmune diseases
- PT4:07 Anifrolumab as rescue therapy in life-threatening, infection-complicated SLE: a biomarker-guided case beyond trial criteria
- Treatment of Alopecia Areata with Anti-Interferon-γ Antibodies
- EP06 Successful treatment of alopecia universalis with rituximab therapy
- Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment
- Resolution of advanced conjunctival squamous cell carcinoma with cemiplimab immunotherapy, IFNα-2b, and retinoic acid treatment over 2 years of follow-up
- CXCR3 Blockade Inhibits T Cell Migration into the Skin and Prevents Development of Alopecia Areata
- Keratin 17 in disease pathogenesis: from cancer to dermatoses
- Minoxidil Sulfate Regulates JAK / STAT Signalling and Mitochondrial Function in Alopecia Areata
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →